BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22334167)

  • 1. Immunodetection analysis of muscular dystrophies in Mexico.
    Gómez-Díaz B; Rosas-Vargas H; Roque-Ramírez B; Meza-Espinoza P; Ruano-Calderón LA; Fernández-Valverde F; Escalante-Bautista D; Escobar-Cedillo RE; Sánchez-Chapul L; Vargas-Cañas S; López-Hernández LB; Bahena-Martínez E; Luna-Angulo AB; Canto P; Coral-Vázquez RM
    Muscle Nerve; 2012 Mar; 45(3):338-45. PubMed ID: 22334167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemistry of sarcolemmal membrane-associated proteins in formalin-fixed and paraffin-embedded skeletal muscle tissue: a promising tool for the diagnostic evaluation of common muscular dystrophies.
    Suriyonplengsaeng C; Dejthevaporn C; Khongkhatithum C; Sanpapant S; Tubthong N; Pinpradap K; Srinark N; Waisayarat J
    Diagn Pathol; 2017 Feb; 12(1):19. PubMed ID: 28219397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
    Lukás Z; Vojtísková M; Fajkusová L; Bednarík J; Kadanka Z; Hájek J; Hermanová M; Vohánka S; Vytopil M
    Cesk Patol; 2001 Nov; 37(4):137-45. PubMed ID: 11813630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA-fragmentation and expression of apoptosis-related proteins in muscular dystrophies.
    Tews DS; Goebel HH
    Neuropathol Appl Neurobiol; 1997 Aug; 23(4):331-8. PubMed ID: 9292873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysferlin protein analysis in limb-girdle muscular dystrophies.
    Vainzof M; Anderson LV; McNally EM; Davis DB; Faulkner G; Valle G; Moreira ES; Pavanello RC; Passos-Bueno MR; Zatz M
    J Mol Neurosci; 2001 Aug; 17(1):71-80. PubMed ID: 11665864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late-onset distal muscular dystrophy affecting the posterior calves.
    Katz JS; Rando TA; Barohn RJ; Saperstein DS; Jackson CE; Wicklund M; Amato AA
    Muscle Nerve; 2003 Oct; 28(4):443-8. PubMed ID: 14506716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aquaporin-4 expression is severely reduced in human sarcoglycanopathies and dysferlinopathies.
    Assereto S; Mastrototaro M; Stringara S; Gazzerro E; Broda P; Nicchia GP; Svelto M; Bruno C; Nigro V; Lisanti MP; Frigeri A; Minetti C
    Cell Cycle; 2008 Jul; 7(14):2199-207. PubMed ID: 18641458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The childhood muscular dystrophies: making order out of chaos.
    Tsao CY; Mendell JR
    Semin Neurol; 1999; 19(1):9-23. PubMed ID: 10711985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limb girdle muscular dystrophy type 2A in India: a study based on semi-quantitative protein analysis, with clinical and histopathological correlation.
    Pathak P; Sharma MC; Sarkar C; Jha P; Suri V; Mohd H; Singh S; Bhatia R; Gulati S
    Neurol India; 2010; 58(4):549-54. PubMed ID: 20739790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common pathological mechanisms in mouse models for muscular dystrophies.
    Turk R; Sterrenburg E; van der Wees CG; de Meijer EJ; de Menezes RX; Groh S; Campbell KP; Noguchi S; van Ommen GJ; den Dunnen JT; 't Hoen PA
    FASEB J; 2006 Jan; 20(1):127-9. PubMed ID: 16306063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dystrophin and dystrophin-associated proteins. Their evaluation at the neuromuscular pathology laboratory].
    Navarro C
    Rev Neurol; 1999 Jan 16-31; 28(2):154-8. PubMed ID: 10101784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patients.
    Hermanová M; Zapletalová E; Sedlácková J; Chrobáková T; Letocha O; Kroupová I; Zámecník J; Vondrácek P; Mazanec R; Maríková T; Vohánka S; Fajkusová L
    Muscle Nerve; 2006 Mar; 33(3):424-32. PubMed ID: 16372320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunocytochemical analysis of human muscular dystrophy.
    Sewry CA
    Microsc Res Tech; 2000 Feb 1-15; 48(3-4):142-54. PubMed ID: 10679962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dystrophin detection by immunofluorescent technique for diagnosing muscular dystrophy].
    Wang X; Xie Y; Zhang C; Liu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):239-42. PubMed ID: 12048687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Updates in muscular dystrophies].
    Erazo-Torricelli R
    Rev Neurol; 2004 Nov 1-15; 39(9):860-71. PubMed ID: 15543503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dystrophin assay in muscular dystrophies: an Indian experience.
    Jain S; Sarkar C; Dinda AK; Maheshwari MC
    Natl Med J India; 1993; 6(6):259-62. PubMed ID: 7950930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
    Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
    Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital muscular dystrophy with merosin deficiency.
    Tomé FM; Evangelista T; Leclerc A; Sunada Y; Manole E; Estournet B; Barois A; Campbell KP; Fardeau M
    C R Acad Sci III; 1994 Apr; 317(4):351-7. PubMed ID: 8000914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiplex Western blotting system for the analysis of muscular dystrophy proteins.
    Anderson LV; Davison K
    Am J Pathol; 1999 Apr; 154(4):1017-22. PubMed ID: 10233840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HyperCKemic, proximal muscular dystrophies and the dystrophin membrane cytoskeleton, including dystrophinopathies, sarcoglycanopathies, and merosinopathies.
    Hoffman EP; Clemens PR
    Curr Opin Rheumatol; 1996 Nov; 8(6):528-38. PubMed ID: 9018456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.